Skip to main content

Table 7 Predicted interactions found from biclusters constructed using rows as human proteins and columns as viral proteins (Sl. No. 1 to 10) and rows as viral proteins and columns as human proteins(Sl. No. 11 to 24)

From: Incorporating the type and direction information in predicting novel regulatory interactions between HIV-1 and human proteins using a biclustering approach

Sl. No. HIV-protein Human protein Interaction types Pubmed id
1 env_gp160 CCL4 Inhibited by 21118814
2 env_gp160 CCL5 Inhibited by 21118814
3 env_gp160 HDAC6 Inhibited by 16148047
4 Rev IPO7 Imported by 16704975
5 capsid IPO7 Imported by 20147401
6 Rev CD4 Inhibited by 8573391
7 matrix NFKBIA inhibited by 10722660
8 Capsid APOBEC3G Interacts with 17065315
9 Vif TP53 Interacts with 21071676
10 RT CD4 Interacts with 22426469
11 Vif MAPK3 Phosphorylated by 10074203
12 Vif UBB Ubiquitinated by 15781449
13 Vif UBD Ubiquitinated by 18596088
14 Vif MAPK1 Ubiquitinated by 10074203
15 Gag_Pr55 IFNA16 Inhibited by 11197304
16 Gag_Pr55 IFNA7 Inhibited by 8553538
17 Tat CD4 Interacts with 12457987
18 Tat PRKCQ Interacts with 9446795
19 Tat LCK Interacts with 18854243
20 p6 MAPK3 Phosphorylated by 11773377
21 p6 MAPK1 Phosphorylated by 15155723
22 Gag_Pr55 IFNA2 Inhibited by 8553538
23 env_gp160 TP53 Interacts with 19023333
24 Nef CD28 Interacts with 21819585
  1. Here the direction of the interactions are taken from human to viral proteins.